Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 06, 2021 08:00 ET | Source: Orca Bio

Orca Bio to Present at the 39th Annual J.P. Morgan Healthcare Conference

MENLO PARK, Calif., Jan. 06, 2021 (GLOBE NEWSWIRE) -- Orca Bio, a clinical-stage biotechnology company developing high-precision cell therapies for patients with blood diseases, today announced that...
December 06, 2020 12:30 ET | Source: Orca Bio

First Clinical Data from Ongoing Orca-T Trial Shows Significantly Improved 12-Month Graft Versus Host Disease (GvHD)-Free and Relapse-Free Survival (GRFS) in Blood Cancer Patients Receiving a Hematopoietic Stem Cell Transplant (HSCT)

— Early multi-center results indicate that Orca-T, a novel approach to HSCT, improves time-to-engraftment, markedly reduces the incidence and severity of GvHD, and significantly improved GRFS at 1...
November 04, 2020 12:51 ET | Source: Orca Bio

Orca Bio Announces Oral Presentation of Orca-T Clinical Data at the 62nd American Society of Hematology (ASH) Annual Meeting

-- Data provide insights into manufacturing efficiency, logistics and early clinical outcomes of Orca-T for patients with blood cancers -- MENLO PARK, Calif., Nov. 04, 2020 (GLOBE NEWSWIRE) -- Orca...
October 14, 2020 07:30 ET | Source: Orca Bio

Orca Bio Receives Regenerative Medicine Advanced Therapy (RMAT) Designation for Orca-T

MENLO PARK, Calif., Oct. 14, 2020 (GLOBE NEWSWIRE) -- Orca Bio, a clinical-stage biotechnology company, today announced that the U.S. Food and Drug Administration (FDA) has granted RMAT designation...
September 02, 2020 07:30 ET | Source: Orca Bio

Orca Bio and Lyell Immunopharma Announce Research Partnership

— The partnership promotes complementary scientific technologies to develop next generation cell-based therapies for patients with solid cancers — MENLO PARK, Calif. and SOUTH SAN FRANCISCO,...
June 17, 2020 07:00 ET | Source: Orca Bio

Orca Bio Emerges With Nearly $300 Million to Transform Allogeneic Cell Therapy

Company aims to safely and effectively regenerate a healthy blood and immune system for patients with hematological malignancies, genetic diseases and autoimmune disorders High precision cell...